Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines

International Journal of Pharmaceutics

Volumn 325, Issue 1-2, 2006, Pages 108-115

  Díaz, Cecilia ^a   Vargas, Ernesto ^a   Gätjens Boniche, Omar ^b  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b INSTITUTO TECNOLÓGICO DE COSTA RICA   (Costa Rica)

Author keywords

Cytotoxicity; Galactose; Hepatocellular carcinoma; Liposome; Retinoic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ASIALOGLYCOPROTEIN RECEPTOR; CATION; GALACTOSE; GLUCOSYLSPHINGOSINE; GLYCOLIPID; ISOTRETINOIN; LIPOSOME; PHOSPHATIDYLCHOLINE; PSYCHOSINE; RETINOIC ACID; RETINOID; SUGAR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; DRUG DELIVERY SYSTEM; EMULSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER TUMOR; MICELLE; MOUSE; MYOBLAST; NONHUMAN; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TISSUE SPECIFICITY; TUMOR CELL;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GALACTOSE; HUMANS; ISOTRETINOIN; LIPOSOMES; MYOBLASTS; SPHINGOSINE; TRETINOIN;

EID: 33749996638     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.06.034     Document Type: Article

References (34)

1. Arce F., Gätjens-Boniche O., Vargas E., Valverde B., and Díaz C. Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett. 229 (2005) 271-281
2. Bosch F.X., Ribes J., Cleries R., and Díaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9 (2005) 191-211
3. Chien P.Y., Wang J., Carbonaro D., Lei S., Miller B., Sheikh S., Ali S.M., Ahmad M.U., and Ahmad I. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther. 12 (2005) 321-328
4. Cho C.S., Cho K.Y., Park I.K., Kim S.H., Sasagawa T., Uchiyama M., and Akaike T. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(l-lactic acid) nanoparticles coated with galactose-carrying polystyrene. J. Controlled Release 77 (2001) 7-15
5. Dass C.R., and Su T. Particle-mediated intravascular delivery of oligonucleotides to tumors: associated biology and lessons from genotherapy. Drug Deliv. 8 (2001) 191-213
6. De Rosa F.S., Marchetti J.M., Thomazini J.A., Tedesco A.C., and Bentley M.V. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulfphoxide on 5-amino-levulinic acid in vitro cutaneous permeation and in vivo photoporphyrin IX accumulation determined by confocal microscopy. J. Controlled Release 65 (2000) 359-366
7. Dragsten P.R., Mitchell D.B., Covert G., and Baker T. Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor. Biochim. Biophys. Acta 926 (1987) 270-279
8. Felnerova D., Viret J.F., Gluck R., and Moser C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr. Opin. Biotecnol. 15 (2004) 518-529
9. Filion M.C., and Phillips N.C. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1329 (1997) 345-356
10. Finlay I.G., Stewart G.J., Pourgholami M.H., Akhter J., and Morris D.L. The use of lipiodol and medium chain triglyceride as delivery agents for hepatic arterial administration of 1,25-dihydroxyvitamin D3-A potential new treatment for hepatocellular carcinoma. Anticancer Res. 20 (2002) 2705-2709
11. Fisher J. Liver cancer on the rise. Ann. Int. Medicine 142 (2005) 1029-1032
12. Goodman C.M., McCusker C.D., Yilmaz T., and Rotello V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 15 (2004) 897-900
13. Hashida M., Nishikawa M., Yamashita F., and Takakura Y. Cell-specific delivery of genes with glycosilated carriers. Adv. Drug Deliv. Rev. 52 (2001) 187-196
14. Hyodo I., Mizuno M., Yamada G., and Tsuji T. Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma. Liver 13 (1993) 80-85
15. Ishida E., Managit C., Kawakami S., Nishikawa M., Yamashita F., and Hashida M. Biodistribution characteristicas of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. Pharm. Res. 21 (2004) 932-939
16. Jin Y., Li J., Rong L.F., Li Y.H., Guo L., and Xu S.Y. Anti-hepatocarcinoma effects of 5-fluorouracil encapsulated by galactosylceramide liposomes in vivo and in vitro. World J. Gastroenterol. 11 (2005) 2643-2646
17. Kawakami S., Yamashita F., Nishikawa M., Takakura Y., and Hashida M. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem. Biophys. Res. Commun. 252 (1998) 78-83
18. Kim C.K., and Lim S.J. Recent progress in drug delivery systems for anticancer agents. Arch. Pharm. Res. 25 (2002) 229-239
19. Ledda-Columbano G.M., Pibiri M., Molotzu F., Cossu C., Senna L., Simbula G., Perra A., and Columbano A. Induction of hepatocyte proliferation by retinoic acid. Carcinogenesis 25 (2004) 2061-2066
20. Lee J.S., Newman R.A., Lippmann S.M., Huber M.H., Minor T., Raber M.N., Krakoff I.H., and Hong W.K. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J. Clin. Oncol. 11 (1993) 959-966
21. Leung T.W.T., and Johnson P.J. Systemic therapy for hepatocellular carcinoma. Sem. Oncol. 28 (2001) 514-520
22. Manconi M., Sinico C., Valenti D., Loy G., and Fadda A.M. Niosomes as carriers for tretinoin. I. Preparation and properties. Int. J. Pharm. 234 (2002) 237-248
23. Mehta K. Interaction of liposome-encapsulated retinoids with normal and leukemic cells. Pharm. Skin 3 (1989) 74-80
24. Muto Y., Moriwaki H., and Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. New Engl. J. Med. 340 (1999) 1046-1047
25. Nastruzzi C., Walde P., Menegatti E., and Gambari R. Liposome-associated retinoic acid. Increased in vitro anti-proliferative effects on neoplastic cells. FEBS Lett. 259 (1990) 293-296
26. Okuno M., Sano T., Matsushima-Nishiwaki R., Adachi S., Akita K., Okano Y., Kojima S., and Moriwaki H. Apoptosis induction by acyclic retinoid: a molecular basis of clonal deletion therapy for hepatocellular carcinoma. Jpn. J. Clin. Oncol. 3 (2001) 359-362
27. Petterson F., Dalgleish A.G., Bissonnette R.P., and Colston K.W. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-γ and altered expression of Bcl-2/Bax. Brit. J. Cancer 87 (2002) 555-561
28. Rando R.R., and Bangerter F.W. The rapid intermembraneous transfer of retinoids. Biochem. Biophys. Res. Commun. 104 (1982) 430-436
29. Shimizu K., Tamagawa K., Takahashi N., Takayama K., and Maitani Y. Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture. Int. J. Pharm. 258 (2003) 45-53
30. Stio M., Celli A., and Treves C. Synergistic effect of vitamin D derivatives and retinoids on C2C12 skeletal muscle cells. IUBMB Life 53 (2002) 175-181
31. Sun S.Y., and Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit. Rev. Oncol. Hematol. 4 (2002) 41-55
32. Takahashi N., Tamagawa K., Shimizu K., Fukui T., and Maitani Y. Effects on M5076-hepatic metastasis of retinoic acid and N-(4-Hydroxyphenyl) retinamide, fenretinide entrapped in SG-liposomes. Bio. Pharm. Bull. 26 (2003) 1060-1063
33. Treré D., Fiume L., DeGiorgi B., DiStefano G., Migaldi M., and Derenzini M. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells. Brit. J. Cancer 81 (1999) 404-408
34. Wu J., Nantz M.H., and Zern M.A. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front. Biosci. 7 (2002) d717-d725